Klotho Neurosciences Inc.

NASDAQ: KLTO · Real-Time Price · USD
0.68
-0.04 (-5.37%)
At close: Aug 21, 2025, 3:59 PM
0.72
6.41%
Pre-market: Aug 22, 2025, 07:24 AM EDT

Klotho Neurosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
63.74K 2.81K 75.87K 300.85K
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a 250K n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
157.81K 6.65K 329.54K 304.52K
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
2.3M 2.19M 2.21M 736.98K
Total Long-Term Assets
2.3M 2.19M 2.21M 736.98K
Total Assets
2.46M 2.19M 2.54M 1.04M
Account Payables
63.69K 151.26K 8.01K 15.13K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
271.75K 1.47M 1.35M n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
1.25M 1.62M 1.36M 15.13K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
24.49K n/a 4.34M n/a
Total Long-Term Liabilities
24.49K n/a 4.42M n/a
Total Liabilities
1.27M 1.62M 1.36M 15.13K
Total Debt
271.75K 1.47M 1.35M n/a
Common Stock
2.71K 1.51K 855.89K 104.49K
Retained Earnings
-10.56M -3.92M -3.22M -2.62M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
1.19M 571.72K 1.18M 1.03M
Total Investments
n/a n/a 117.81M n/a